EBT, Grant of Ordinary Shares and TVR

RNS Number : 7098K
Numis Corporation PLC
06 September 2021
 

NUMIS CORPORATION PLC ("Numis") 

 

MONDAY 6 SEPTEMBER 2021  

 

EMARGOED FOR RELEASE AT 7.00 am

 

 

Numis Corporation Plc Employee Benefit Trust No.2 ("EBT No.2")

 

EBT, Grant of Ordinary Shares and Total Voting Rights

 

The Board of Numis announces today, that it issued to the Numis Corporation Plc Employee Benefit Trust No.2 ("EBT No.2") 6,600,000 ordinary shares at nominal value of 5p per share, equivalent to 6.13% of the Company's issued share capital, to fund scheduled award vestings under Numis' various employee share schemes. There will be no voting rights attached to the EBT Shares whilst they are held in the EBT.

 

Application has been made for the EBT Shares, which will rank pari passu with the Company's existing issued ordinary shares, to be admitted to trading on AIM. It is expected that admission will become effective and that trading in the EBT Shares will commence on or around 7 September 2021 ("Admission").

 

The EBT No.2 is deemed interested in 7,031,289 (6.15%) Numis ordinary shares of 5p each. 

 

The Numis shares referred to above are Numis' ordinary shares of 5p each and the total number of shares in issue following the listing of 6,600,000 shares is 125,038,536  with each ordinary share carrying the right to one vote. The figure of 114,367,448 (excluding shares held in treasury) may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

The total number of shares held in treasury is 10,671,088 (9.33%).  It is expected that all shares held in Treasury will be cancelled following the next Annual General Meeting scheduled for, 8 February 2022.

 

The total number of voting rights in Numis is 114,367,448

 

These details have been provided in accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014.

 

 

6 September 2021 

 

 

END

 

 

 

 

 

 

Contacts

Noreen Biddle-Shah, Head of Corporate Communications  020 7260 1441

 

Brunswick:

Nick Cosgrove    020 7404 5959

Simone Selzer   020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser): 

Philip Secrett    020 7728 2578

Harrison J Clarke  020 7865 2411

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFEIASIVIIL
UK 100

Latest directors dealings